Home / Inspections / 1203720

FDA Inspection 1203720 — Vitalant Magee Women's Hospital Site

Vitalant Magee Women's Hospital Site — FEI 3004866289

The FDA completed an inspection of Vitalant Magee Women's Hospital Site on April 11, 2023 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 11, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pittsburgh, PA (United States)

Facility

Other inspections at this facility

  • 1277487 (NAI Wed Jul 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1096150 (NAI Mon Jun 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1000616 (VAI Mon Jan 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 911620 (NAI Wed Jan 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 816136 (NAI Wed Jan 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources